Ligand · 4Z8
4Z8 · 2,2-dimethyl-3-[(4-{[2-methyl-1-(propan-2-yl)-1H-imidazo[4,5-c]pyridin-6-yl]amino}pyrimidin-2-yl) amino]propanamide
4Z8, 2,2-dimethyl-3-[(4-{[2-methyl-1-(propan-2-yl)-1H-imidazo[4,5-c]pyridin-6-yl]amino}pyrimidin-2-yl) amino]propanamide (C19 H26 N8 O, 382.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- 4Z8
- Formula
- C19 H26 N8 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
4Z8 in 2 structures; the first of them:
- 5CAL · EGFR kinase domain mutant TMLR" with compound 24" · 4Z8 A1101 · binds LEU718, PHE723, VAL726, ALA743, LYS745, CYS775, MET790, GLN791 and 9 more
- 5CAL · EGFR kinase domain mutant "tmlr" with compound 24 · 4Z8 A1101 · binds LEU718, PHE723, VAL726, ALA743, LYS745, CYS775, MET790, GLN791 and 9 more
Residues it binds most
LEU 2, MET 2, ALA 2, ARG 2, ASN 2, ASP 2, CYS 2, GLN 2, GLY 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.